Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.
Coirini
H
H
Laboratory of Neuroendocrinology, Rockefeller University, New York, NY 10021.
Schumacher
M
M
Angulo
J A
JA
McEwen
B S
BS
D000818:Animals; D001483:Base Sequence; D002421:Caudate Nucleus / Q000187:drug effects / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000502:physiology; D006220:Haloperidol / Q000494:pharmacology*; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D008969:Molecular Sequence Data; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D016627:Oxidopamine; D011699:Putamen / Q000187:drug effects / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism*
D006892:Hydroxydopamines; D012333:RNA, Messenger; D011954:Receptors, Dopamine; D016627:Oxidopamine; D006220:Haloperidol; D004298:Dopamine